Sagtec Global clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Sagtec Global Ltd
SAGT · NASDAQ · USD · Market cap $12M · 20 employees
Sagtec Global Limited, together with its subsidiaries, engages in the provision of customizable software solutions in Malaysia.
Not yet scoredPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 04:19 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price1.08 USD at the 13 Nov 2026 close
- Our regime readMarkup, as of 15 Nov 2026
- Ethical screenNot yet scored
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-13).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Sagtec Global Ltd holds its Markup at $1.08. Consolidating, no directional conviction, held for 11 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 11 days |
| Price at the screen | $1.08 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | Not scored · score 70.0 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 5.48% | Below 33% | Interest-bearing debt is just 5.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 16.40% | Below 49% | Money owed to the company is 16.4% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Sagtec Global clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.
Sagtec Global clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 5%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
The Business, in Plain Words| EPS, trailing | 0.00 |
| Revenue growth | +1.4%slow but positive growth |
| Profit margin | 8.3%thin but positive margins |
| Return on equity | 7.7%a modest return on shareholder capital |
| FCF yield | 82.00% |
| Debt to equity | 4.77heavy leverage: higher risk if revenue softens |
| Current ratio | 3.12comfortably covers its short-term bills |
| Short interest, float | 0.00% |
| 52-week range | 0.52 - 3.39 |
| Moat | NONE |
| Market cap | $12M |
| Employees | 20 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Malaysia and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSAGT trades on NASDAQ (the company is based in Malaysia). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 49.8% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 48%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 50.6% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 48%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 34.2% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are down 48%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are down 48%. Our forward projection puts the odds of a 10% gain over the next month near 23%. Since the last review it its composite score rose.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 28.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are down 48%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are down 48%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are down 48%. Our forward projection puts the odds of a 10% gain over the next month near 23%.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Sagtec Global Announces Successful Corporate Name Change of Subsidiary to CLAI Tech Sdn. Bhd. Yahoo Finance · 13 Oct 2026
- Sagtec Global Introduces “CLAi 1.0” to Expand Its Enterprise AI Solutions and Create New Technology Revenue Opportunities Yahoo Finance · 6 Oct 2026
- New to The Street Show 773 Premieres Tonight on Bloomberg Television, Featuring Glint, Sagtec Global, BioVie and SafeSpace Global Yahoo Finance · 26 Sep 2026
- Sagtec Global Completes Strategic Private Placement with His Royal Highness Prince Hassanal of Pahang, Malaysia Yahoo Finance · 18 Sep 2026
- Sagtec Reports 46 Percent Gross Profit Growth and Expands International Business Momentum Yahoo Finance · 16 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1.37 | -18.0% | · | $821 | -18.0% |
| 2 months | $1.82 | -38.5% | · | $615 | -38.5% |
| 3 months | $2.32 | -51.7% | · | $483 | -51.7% |
| 6 months | $2.21 | -49.2% | · | $508 | -49.2% |
| 1 year | $2.14 | -47.7% | · | $523 | -47.7% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SAGT does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.